GILDER GAGNON HOWE & CO LLC – Alnylam Pharmaceuticals, Inc. Transaction History
GILDER GAGNON HOWE & CO LLC portfolio value:
$132.90M
portfolio value
GILDER GAGNON HOWE & CO LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.01% | -90.59K shares | 22.84M | $200.16 | 663.98K |
| Q2 2022 | share | Decrease | -4.63% | -36.64K shares | -19.14M | $145.85 | 754.57K |
| Q1 2022 | share | Decrease | -5.76% | -48.34K shares | -13.17M | $163.29 | 791.22K |
| Q4 2021 | share | Decrease | -9.11% | -84.11K shares | -32.02M | $171.03 | 839.56K |
| Q3 2021 | share | Decrease | -0.22% | -2.04K shares | 17.47M | $188.81 | 923.68K |
| Q2 2021 | share | Decrease | -0.42% | -3.91K shares | 25.67M | $169.52 | 925.72K |
| Q1 2021 | share | Increase | +5.15% | 45.51K shares | 16.34M | $141.19 | 929.64K |
| Q4 2020 | share | Decrease | -0.71% | -6.28K shares | -14.73M | $129.97 | 884.13K |
| Q3 2020 | share | Increase | +0.75% | 6.64K shares | -1.25M | $145.6 | 890.41K |
| Q2 2020 | share | Decrease | -3.85% | -35.40K shares | 30.84M | $148.11 | 883.76K |
| Q1 2020 | share | Decrease | -1.85% | -17.30K shares | -7.80M | $108.85 | 919.17K |
| Q4 2019 | share | Decrease | -1.85% | -17.62K shares | 31.12M | $115.17 | 936.47K |
| Q3 2019 | share | Decrease | -2.43% | -23.71K shares | 5.77M | $80.42 | 954.10K |
| Q2 2019 | share | Decrease | -1.01% | -9.95K shares | -21.35M | $72.56 | 977.81K |
| Q1 2019 | share | Increase | +3.48% | 33.17K shares | 22.70M | $93.45 | 987.77K |
| Q4 2018 | share | Decrease | -12.33% | -134.29K shares | -25.7M | $72.91 | 954.59K |
| Q3 2018 | share | Decrease | -0.53% | -5.82K shares | -12.51M | $87.52 | 1.08M |
| Q2 2018 | share | Decrease | -9.56% | -115.70K shares | -36.34M | $98.49 | 1.09M |
| Q1 2018 | share | Decrease | -0.57% | -6.94K shares | -10.50M | $119.1 | 1.21M |
| Q4 2017 | share | Increase | +8.64% | 96.81K shares | 23.01M | $127.05 | 1.21M |
| Q3 2017 | share | Decrease | -5.47% | -64.82K shares | 37.10M | $117.49 | 1.12M |
| Q2 2017 | share | Decrease | -1.71% | -20.66K shares | 32.73M | $79.76 | 1.18M |
| Q1 2017 | share | Decrease | -2.01% | -24.74K shares | 15.72M | $51.25 | 1.20M |
| Q4 2016 | share | Decrease | -9.61% | -130.86K shares | -46.21M | $37.44 | 1.23M |
| Q3 2016 | share | Decrease | -2.32% | -32.29K shares | 14.94M | $67.78 | 1.36M |
| Q2 2016 | share | Decrease | -1.46% | -20.68K shares | -11.44M | $55.49 | 1.39M |
| Q1 2016 | share | Decrease | -4.25% | -62.73K shares | -50.28M | $62.77 | 1.41M |